Summary: Evaluated catheter ablation versus antiarrhythmic drug therapy in patients with atrial fibrillation. The primary endpoint of freedom from atrial fibrillation was reduced with ablation (65%) versus antiarrhythmic drugs (41%). The trial is still enrolling with a goal of 3000 patients. The new primary endpoint is mortality with multiple secondary endpoints.
None available. Results presented at national conferences.
Eponym: Catheter ABlation versus ANtiarrhythmic Drug Therapy for Atrial Fibrillation